Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019

Date: February 29, 2012
Pages: 71
Price:
US$ 3,995.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HD9BDCDBAF7EN
Leaflet:

Download PDF Leaflet

Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, “Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Haemophilus influenzae type B vaccine Therapeutics market. The report identifies the key trends shaping and driving the global Haemophilus influenzae type B vaccine Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Haemophilus influenzae type B vaccine Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Haemophilus influenzae type B vaccine Therapeutics market. Its scope includes -
  • Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Haemophilus influenzae type B vaccine Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
  • Analysis of the current and future competition in the seven key countries Haemophilus influenzae type B vaccine Therapeutics market.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Haemophilus influenzae type B vaccine Therapeutics market.
  • Analysis of key recent licensing and partnership agreements in Haemophilus influenzae type B vaccine Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global Haemophilus influenzae type B vaccine Therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Haemophilus influenzae type B vaccine Therapeutics market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What’s the next big thing in the global Haemophilus influenzae type B vaccine Therapeutics market landscape? – Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 HAEMOPHILUS INFLUENZAE TYPE B (HIB) VACCINES - INTRODUCTION

2.1 Disease Overview
2.2 Epidemiology
2.3 Disease Burden
2.4 Etiology
2.5 Pathophysiology
2.6 Signs and Symptoms
2.7 Diagnosis
2.8 Treatment and Management Options
2.9 GlobalData Pipeline Report Guidance

3 HAEMOPHILUS INFLUENZAE TYPE B VACCINES - MARKET CHARACTERIZATION

3.1 Overview
3.2 Haemophilus Influenzae Type b Vaccines Market Size (2006-2011) - Global
3.3 Haemophilus Influenzae Type b Vaccines Market Forecast (2011-2019) - Global
3.4 Haemophilus Influenzae Type b Vaccines Market Size (2006-2011) - the US
3.5 Haemophilus Influenzae Type b Vaccines Market Forecast (2011-2019) - the US
3.6 Haemophilus Influenzae Type b Vaccines Market Size (2006-2011) - France
3.7 Haemophilus Influenzae Type b Vaccines Market Forecast (2011-2019) - France
3.8 Haemophilus Influenzae Type b Vaccines Market Size (2006-2011) - Germany
3.9 Haemophilus Influenzae Type b Vaccines Market Forecast (2011-2019) - Germany
3.10 Haemophilus Influenzae Type b Vaccines Market Size (2006-2011) - Italy
3.11 Haemophilus Influenzae Type b Vaccines Market Forecast (2011-2019) - Italy
3.12 Haemophilus Influenzae Type b Vaccines Market Size (2006-2011) - Spain
3.13 Haemophilus Influenzae Type b Vaccines Market Forecast (2011-2019) - Spain
3.14 Haemophilus Influenzae Type b Vaccines Market Size (2006-2011) - the UK
3.15 Haemophilus Influenzae Type b Vaccines Market Forecast (2011-2019) - the UK
3.16 Haemophilus Influenzae Type b Vaccines Market Size (2006-2011) - Japan
3.17 Haemophilus Influenzae Type b Vaccines Market Forecast (2011-2019) - Japan
3.18 Drivers and Barriers for the Haemophilus Influenzae Type b Vaccines Market
  3.18.1 Drivers for the Haemophilus Influenzae Type b Vaccines Market
  3.18.2 Barriers for the Haemophilus Influenzae Type b Vaccines Market
3.19 Opportunity and Unmet Need
3.20 Key Takeaway

4 HAEMOPHILUS INFLUENZAE TYPE B VACCINES - COMPETITIVE ASSESSMENT

4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for the Major Marketed Vaccines in the Haemophilus Influenzae Type b Vaccines Market
  4.3.1 ActHIB
  4.3.2 PedvaxHIB
  4.3.3 Pediacel
  4.3.4 Menitorix
  4.3.5 Hiberix
4.4 Key Takeaway

5 HAEMOPHILUS INFLUENZAE TYPE B VACCINES - PIPELINE ASSESSMENT

5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Haemophilus Influenzae Type b Vaccines - Pipeline Analysis by Clinical Phase of Development
  5.3.1 Haemophilus Influenzae Type b Vaccines - Phase III and Regulatory Filed Clinical Pipeline
  5.3.2 Haemophilus Influenzae Type b Vaccines - Phase II Clinical Pipeline
  5.3.3 Haemophilus Influenzae Type b Vaccines - Phase I Pipeline
  5.3.4 Haemophilus Influenzae Type b Vaccines - Pre-clinical and Discovery Phase Pipeline
5.4 Haemophilus Influenzae Type b Vaccines - Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework
5.6 Haemophilus Influenzae Type b Vaccines - Most Promising Drugs in Clinical Development
  5.6.1 MenHibrix
  5.6.2 Hexaxim
  5.6.3 V419
  5.6.4 DTwP-HB-Hib Vaccine
  5.6.5 TAK-816
5.7 Key Takeaway

6 HAEMOPHILUS INFLUENZAE TYPE B VACCINES: CLINICAL TRIALS MAPPING

6.1 Overview
6.2 Clinical Trials by Region/Country (the US, EU5 and Japan)
6.3 Clinical Trials by Phase of Clinical Development
6.4 Clinical Trials by Trial Status
6.5 Prominent Sponsors
6.6 Clinical Trials by Sponsors
6.7 Top Companies Participating in Haemophilus Influenzae Type b Vaccines Clinical Trials
6.8 Key Takeaway

7 HAEMOPHILUS INFLUENZAE TYPE B VACCINES - STRATEGIC ASSESSMENT

7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario

8 HAEMOPHILUS INFLUENZAE TYPE B VACCINES: FUTURE PLAYERS

8.1 Introduction
8.2 Company Profiles
  8.2.1 Sanofi Pasteur
  8.2.2 GlaxoSmithKline
  8.2.3 LG Life Sciences Ltd
  8.2.4 Merck & Co., Inc.
  8.2.5 Novartis AG
8.3 Other Companies in the Haemophilus Influenzae Type b Vaccines Market
8.4 Key Takeaway

9 HAEMOPHILUS INFLUENZAE TYPE B VACCINES - LICENSING & PARTNERSHIP DEALS

10 APPENDIX

10.1 Market Definitions
10.2 Abbreviations
10.3 Research Methodology
  10.3.1 Coverage
  10.3.2 Secondary Research
  10.3.3 Forecasting
  10.3.4 Primary Research
  10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

LIST OF TABLES

Table 1: Characteristics of Type b and Non-typable Strains of Haemophilus Influenzae
Table 2: Haemophilus Influenzae Type b Vaccines Market, Global, Revenue ($m), 2006-2011
Table 3: Haemophilus Influenzae Type b Vaccines Market, Global, Forecast ($m), 2011-2019
Table 4: Haemophilus Influenzae Type b Vaccines Market, the US, Revenue ($m), 2006-2011
Table 5: Haemophilus Influenzae Type b Vaccines Market, the US, Forecast ($m), 2011-2019
Table 6: Haemophilus Influenzae Type b Vaccines Market, France, Revenue ($m), 2006-2011
Table 7: Haemophilus Influenzae Type b Vaccines Market, France, Forecast ($m), 2011-2019
Table 8: Haemophilus Influenzae Type b Vaccines Market, Germany, Revenue ($m), 2006-2011
Table 9: Haemophilus Influenzae Type b Vaccines Market, Germany, Forecast ($m), 2011-2019
Table 10: Haemophilus Influenzae Type b Vaccines Market, Italy, Revenue ($m), 2006-2011
Table 11: Haemophilus Influenzae Type b Vaccines Market, Italy, Forecast ($m), 2011-2019
Table 12: Haemophilus Influenzae Type b Vaccines Market, Spain, Revenue ($m), 2006-2011
Table 13: Haemophilus Influenzae Type b Vaccines Market, Spain, Forecast ($m), 2011-2019
Table 14: Haemophilus Influenzae Type b Vaccines Market, the UK, Revenue ($m), 2006-2011
Table 15: Haemophilus Influenzae Type b Vaccines Market, the UK, Forecast ($m), 2011-2019
Table 16: Haemophilus Influenzae Type b Vaccines Market, Japan, Revenue ($m), 2006-2011
Table 17: Haemophilus Influenzae Type b Vaccines Market, Japan, Forecast ($m), 2011-2019
Table 18: Haemophilus Influenzae Type b Vaccines Market, Phase III and Regulatory Filed Pipeline, 2011
Table 19: Haemophilus Influenzae Type b Vaccines Market, Phase II Pipeline, 2011
Table 20: Haemophilus Influenzae Type b Vaccines Market, Phase I Pipeline, 2011
Table 21: Haemophilus Influenzae Type b Vaccines Market, Pre-clinical and Discovery Phase Pipeline, 2011
Table 22: Haemophilus Influenzae Type b Vaccines Market, Global, Most Promising Drugs in Clinical Development, 2011
Table 23: Haemophilus Influenzae Type b Vaccines, Global, Clinical Trials, 2011
Table 24: Haemophilus Influenzae Type b Vaccines, Global, Clinical Trials by Phase, 2011
Table 25: Haemophilus Influenzae Type b Vaccines, Global, Clinical Trials by Status of Development, 2011
Table 26: Haemophilus Influenzae Type b Vaccines, Global, Prominent Sponsors, 2011
Table 27: Haemophilus Influenzae Type b Vaccines, Global, Overall Sponsors, 2011
Table 28: Haemophilus Influenzae Type b Vaccines, Global, Top Companies by Phase, 2011
Table 29: Sanofi - Haemophilus Influenzae Type b Vaccine Pipeline Portfolio, 2011
Table 30: GlaxoSmithKline - Haemophilus Influenzae Type b Vaccine Pipeline Portfolio, 2011
Table 31: LG Life Sciences - Haemophilus Influenzae Type b Vaccine Pipeline Portfolio, 2011
Table 32: Merck & Co., Inc. - Haemophilus Influenzae Type b Vaccine Pipeline Portfolio, 2011
Table 33: Novartis AG - Haemophilus Influenzae Type b Vaccine Pipeline Portfolio, 2011
Table 34: Haemophilus Influenzae Type b Vaccine Market - Future Players
Table 35: Haemophilus Influenzae Type b Vaccines, Global, Deals - 2011

LIST OF FIGURES

Figure 1: Mortality Rate per 100,000 Children Under the Age of Five due to Haemophilus Influenzae Type b Disease, 2000
Figure 2: Haemophilus Influenzae Type b global annual reported coverage, 1980-2009
Figure 3: Images for Haemophilus influenzae
Figure 4: Haemophilus Influenzae Type b Vaccines Market, Global, Revenue ($m), 2006-2011
Figure 5: Haemophilus Influenzae Type b Vaccines Market, Global, Forecast ($m), 2011-2019
Figure 6: Haemophilus Influenzae Type b Vaccines Market, the US, Revenue ($m), 2006-2011
Figure 7: Haemophilus Influenzae Type b Vaccines Market, the US, Forecast ($m), 2011-2019
Figure 8: Haemophilus Influenzae Type b Vaccines Market, France, Revenue ($m), 2006-2011
Figure 9: Haemophilus Influenzae Type b Vaccines Market, France, Forecast ($m), 2011-2019
Figure 10: Haemophilus Influenzae Type b Vaccines Market, Germany, Revenue ($m), 2006-2011
Figure 11: Haemophilus Influenzae Type b Vaccines Market, Germany, Forecast ($m), 2011-2019
Figure 12: Haemophilus Influenzae Type b Vaccines Market, Italy, Revenue ($m), 2006-2011
Figure 13: Haemophilus Influenzae Type b Vaccines Market, Italy, Forecast ($m), 2011-2019
Figure 14: Haemophilus Influenzae Type b Vaccines Market, Spain, Revenue ($m), 2006-2011
Figure 15: Haemophilus Influenzae Type b Vaccines Market, Spain, Forecast ($m), 2011-2019
Figure 16: Haemophilus Influenzae Type b Vaccines Market, the UK, Revenue ($m), 2006-2011
Figure 17: Haemophilus Influenzae Type b Vaccines Market, the UK, Forecast ($m), 2011-2019
Figure 18: Haemophilus Influenzae Type b Vaccines Market, Japan, Revenue ($m), 2006-2011
Figure 19: Haemophilus Influenzae Type b Vaccines Market, Japan, Forecast ($m), 2011-2019
Figure 20: Opportunity and Unmet Need in the Haemophilus Influenzae Type b (Monovalent) Vaccines Market
Figure 21: Opportunity and Unmet Need in the Haemophilus Influenzae Type b (Combined) Vaccines Market
Figure 22: Strategic Competitor Assessment of the Marketed Products in Haemophilus Influenzae Type b (Monovalent) Vaccines, 2011
Figure 23: Strategic Competitor Assessment of the Marketed Products in Haemophilus Influenzae Type b (Combined) Vaccines, 2011
Figure 24: Haemophilus Influenzae Type b Vaccines Pipeline by Phase of Clinical Development, 2011
Figure 25: Haemophilus Influenzae Type b Vaccines Market, Global, Pipeline by Mechanism of Action (%), 2011
Figure 26: Technology Trends Analytics Framework, 2011
Figure 27: Technology Trends Analytics Frame Work - Description, 2011
Figure 28: Haemophilus Influenzae Type b Vaccines, Global, Clinical Trials by Country, 2011
Figure 29: Haemophilus Influenzae Type b Vaccines, Global, Clinical Trials by Phase (%), 2011
Figure 30: Haemophilus Influenzae Type b Vaccines, Global, Clinical Trials by Status of Development (%), 2011
Figure 31: Haemophilus Influenzae Type b Vaccines, Global, Prominent Sponsors (%), 2011
Figure 32: Haemophilus Influenzae Type b Vaccines, Global, Overall Sponsors (%), 2011
Figure 33: Haemophilus Influenzae Type b Vaccines, Global, Top Companies by Phase, 2011
Figure 34: Haemophilus Influenzae Type b Vaccines Market, Drivers and Restraints, 2011
Figure 35: Implications for Future Market Competition in the Haemophilus Influenzae Type b Vaccines Market, 2011
Figure 36: Haemophilus Influenzae Type b Vaccines Market, Global, Future Players, 2011
Figure 37: GlobalData Market Forecasting Model

COMPANIES MENTIONED

Sanofi Pasteur
GlaxoSmithKline
LG Life Sciences Ltd
Merck & Co., Inc.
Novartis AG

Ask Your Question

Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: